Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-05-20

Clinical Trial Update: Comparison of the Ability of Glulisine With Lispro to Control Type 1 Diabetes Mellitus in Children and Adolescents [Phase 3]

View source ↗

Summary

Phase 3 trial comparing insulin glulisine with insulin lispro for glycemic control in children and adolescents with Type 1 diabetes mellitus; the study has comp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Apidra (insulin glulisine)
  • Humalog (insulin lispro)

Snippet

Sponsor: Sanofi | Conditions: Diabetes Mellitus, Insulin-Dependent | Phase 3 | Status: COMPLETED